SEC Form 4 · accession 0001078782-17-001160
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron John Reynolds
Officer — President and CEO · Director
Period of report
Aug 16, 2017
Accepted (ET)
Aug 17, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 16, 2017 | P | 3,630 | $2.77 | A | 1,007,718 | I | Concord International, Inc. |
| Common Stock | holding | — | — | — | 34,076 | I | By Wife | |
| Common Stock | holding | — | — | — | 1,114,673 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.